nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—CYP2C9—brain cancer	0.443	1	CbGaD
Valproic Acid—CYP1A2—Carmustine—brain cancer	0.0369	0.233	CbGbCtD
Valproic Acid—CYP3A4—Temozolomide—brain cancer	0.0279	0.176	CbGbCtD
Valproic Acid—PTGS1—Etoposide—brain cancer	0.0245	0.154	CbGbCtD
Valproic Acid—CYP3A4—Lomustine—brain cancer	0.0237	0.15	CbGbCtD
Valproic Acid—CYP3A5—Etoposide—brain cancer	0.0147	0.0927	CbGbCtD
Valproic Acid—CYP2C8—Etoposide—brain cancer	0.0141	0.0892	CbGbCtD
Valproic Acid—CYP1A2—Etoposide—brain cancer	0.0109	0.069	CbGbCtD
Valproic Acid—SLC22A8—choroid plexus—brain cancer	0.00687	0.0802	CbGeAlD
Valproic Acid—CYP3A4—Etoposide—brain cancer	0.00573	0.0362	CbGbCtD
Valproic Acid—HDAC2—telencephalic ventricle—brain cancer	0.003	0.035	CbGeAlD
Valproic Acid—ALDH5A1—hindbrain—brain cancer	0.0022	0.0256	CbGeAlD
Valproic Acid—HDAC2—Teniposide—Etoposide—brain cancer	0.00214	1	CbGdCrCtD
Valproic Acid—ABAT—hindbrain—brain cancer	0.00188	0.0219	CbGeAlD
Valproic Acid—OGDH—telencephalon—brain cancer	0.0016	0.0186	CbGeAlD
Valproic Acid—HDAC2—hindbrain—brain cancer	0.00141	0.0165	CbGeAlD
Valproic Acid—HDAC9—telencephalon—brain cancer	0.00141	0.0164	CbGeAlD
Valproic Acid—UGT1A10—endocrine gland—brain cancer	0.00137	0.016	CbGeAlD
Valproic Acid—OGDH—gonad—brain cancer	0.00133	0.0156	CbGeAlD
Valproic Acid—OGDH—pituitary gland—brain cancer	0.0013	0.0152	CbGeAlD
Valproic Acid—UGT1A6—endocrine gland—brain cancer	0.00127	0.0149	CbGeAlD
Valproic Acid—ALDH5A1—brainstem—brain cancer	0.00126	0.0147	CbGeAlD
Valproic Acid—OGDH—medulla oblongata—brain cancer	0.00125	0.0146	CbGeAlD
Valproic Acid—OGDH—spinal cord—brain cancer	0.00112	0.0131	CbGeAlD
Valproic Acid—ALDH5A1—telencephalon—brain cancer	0.00112	0.013	CbGeAlD
Valproic Acid—UGT1A8—endocrine gland—brain cancer	0.00108	0.0126	CbGeAlD
Valproic Acid—ABAT—brainstem—brain cancer	0.00108	0.0126	CbGeAlD
Valproic Acid—UGT1A8—head—brain cancer	0.00107	0.0125	CbGeAlD
Valproic Acid—ACADSB—pituitary gland—brain cancer	0.00103	0.0121	CbGeAlD
Valproic Acid—HDAC9—midbrain—brain cancer	0.00101	0.0118	CbGeAlD
Valproic Acid—OGDH—endocrine gland—brain cancer	0.00101	0.0118	CbGeAlD
Valproic Acid—ACADSB—medulla oblongata—brain cancer	0.000997	0.0116	CbGeAlD
Valproic Acid—OGDH—head—brain cancer	0.000994	0.0116	CbGeAlD
Valproic Acid—UGT1A3—endocrine gland—brain cancer	0.000966	0.0113	CbGeAlD
Valproic Acid—ABAT—telencephalon—brain cancer	0.000955	0.0112	CbGeAlD
Valproic Acid—ALDH5A1—gonad—brain cancer	0.000932	0.0109	CbGeAlD
Valproic Acid—ACADSB—midbrain—brain cancer	0.000911	0.0106	CbGeAlD
Valproic Acid—UGT2B15—endocrine gland—brain cancer	0.000908	0.0106	CbGeAlD
Valproic Acid—OGDH—central nervous system—brain cancer	0.000908	0.0106	CbGeAlD
Valproic Acid—ACADSB—spinal cord—brain cancer	0.000889	0.0104	CbGeAlD
Valproic Acid—OGDH—cerebellum—brain cancer	0.000887	0.0104	CbGeAlD
Valproic Acid—ALDH5A1—medulla oblongata—brain cancer	0.000877	0.0102	CbGeAlD
Valproic Acid—HDAC9—head—brain cancer	0.000877	0.0102	CbGeAlD
Valproic Acid—UGT1A4—endocrine gland—brain cancer	0.000821	0.00959	CbGeAlD
Valproic Acid—HDAC2—brainstem—brain cancer	0.000811	0.00947	CbGeAlD
Valproic Acid—ALDH5A1—midbrain—brain cancer	0.000802	0.00936	CbGeAlD
Valproic Acid—HDAC9—central nervous system—brain cancer	0.0008	0.00934	CbGeAlD
Valproic Acid—ACADSB—endocrine gland—brain cancer	0.0008	0.00934	CbGeAlD
Valproic Acid—ABAT—gonad—brain cancer	0.000797	0.00931	CbGeAlD
Valproic Acid—ALDH5A1—spinal cord—brain cancer	0.000782	0.00914	CbGeAlD
Valproic Acid—HDAC9—cerebellum—brain cancer	0.000782	0.00913	CbGeAlD
Valproic Acid—ABAT—pituitary gland—brain cancer	0.000778	0.00908	CbGeAlD
Valproic Acid—ABAT—medulla oblongata—brain cancer	0.000751	0.00876	CbGeAlD
Valproic Acid—PTGS1—ganglion—brain cancer	0.000744	0.00868	CbGeAlD
Valproic Acid—OGDH—brain—brain cancer	0.000721	0.00841	CbGeAlD
Valproic Acid—HDAC2—telencephalon—brain cancer	0.00072	0.0084	CbGeAlD
Valproic Acid—ACADSB—cerebellum—brain cancer	0.000705	0.00823	CbGeAlD
Valproic Acid—ALDH5A1—endocrine gland—brain cancer	0.000704	0.00822	CbGeAlD
Valproic Acid—ALDH5A1—head—brain cancer	0.000695	0.00812	CbGeAlD
Valproic Acid—UGT1A9—endocrine gland—brain cancer	0.000688	0.00803	CbGeAlD
Valproic Acid—ABAT—midbrain—brain cancer	0.000686	0.00801	CbGeAlD
Valproic Acid—ABAT—spinal cord—brain cancer	0.000669	0.00782	CbGeAlD
Valproic Acid—PTGS1—endothelium—brain cancer	0.000641	0.00749	CbGeAlD
Valproic Acid—SLC16A1—telencephalon—brain cancer	0.000639	0.00747	CbGeAlD
Valproic Acid—HDAC9—brain—brain cancer	0.000635	0.00742	CbGeAlD
Valproic Acid—ALDH5A1—central nervous system—brain cancer	0.000635	0.00741	CbGeAlD
Valproic Acid—ALDH5A1—cerebellum—brain cancer	0.00062	0.00724	CbGeAlD
Valproic Acid—ABAT—endocrine gland—brain cancer	0.000603	0.00704	CbGeAlD
Valproic Acid—CYP2C18—endocrine gland—brain cancer	0.000601	0.00702	CbGeAlD
Valproic Acid—HDAC2—gonad—brain cancer	0.000601	0.00701	CbGeAlD
Valproic Acid—ABAT—head—brain cancer	0.000595	0.00695	CbGeAlD
Valproic Acid—PTGS1—blood vessel—brain cancer	0.000591	0.0069	CbGeAlD
Valproic Acid—HDAC2—pituitary gland—brain cancer	0.000586	0.00684	CbGeAlD
Valproic Acid—ACADSB—brain—brain cancer	0.000572	0.00668	CbGeAlD
Valproic Acid—HDAC2—medulla oblongata—brain cancer	0.000565	0.0066	CbGeAlD
Valproic Acid—UGT2B7—endocrine gland—brain cancer	0.000555	0.00647	CbGeAlD
Valproic Acid—ABAT—central nervous system—brain cancer	0.000543	0.00634	CbGeAlD
Valproic Acid—SLC16A1—gonad—brain cancer	0.000534	0.00623	CbGeAlD
Valproic Acid—ABAT—cerebellum—brain cancer	0.000531	0.0062	CbGeAlD
Valproic Acid—SLC22A7—endocrine gland—brain cancer	0.000528	0.00616	CbGeAlD
Valproic Acid—SLC16A1—pituitary gland—brain cancer	0.000521	0.00608	CbGeAlD
Valproic Acid—HDAC2—midbrain—brain cancer	0.000517	0.00603	CbGeAlD
Valproic Acid—ALDH5A1—brain—brain cancer	0.000504	0.00588	CbGeAlD
Valproic Acid—SLC16A1—medulla oblongata—brain cancer	0.000502	0.00587	CbGeAlD
Valproic Acid—SLC16A1—midbrain—brain cancer	0.000459	0.00536	CbGeAlD
Valproic Acid—HDAC2—endocrine gland—brain cancer	0.000454	0.0053	CbGeAlD
Valproic Acid—HDAC2—head—brain cancer	0.000448	0.00523	CbGeAlD
Valproic Acid—SLC16A1—spinal cord—brain cancer	0.000448	0.00523	CbGeAlD
Valproic Acid—ABAT—brain—brain cancer	0.000431	0.00503	CbGeAlD
Valproic Acid—HDAC2—central nervous system—brain cancer	0.000409	0.00478	CbGeAlD
Valproic Acid—SLC16A1—endocrine gland—brain cancer	0.000403	0.00471	CbGeAlD
Valproic Acid—HDAC2—cerebellum—brain cancer	0.0004	0.00467	CbGeAlD
Valproic Acid—SLC16A1—head—brain cancer	0.000398	0.00465	CbGeAlD
Valproic Acid—SLC22A7—brain—brain cancer	0.000377	0.00441	CbGeAlD
Valproic Acid—SLC22A6—brain—brain cancer	0.000364	0.00425	CbGeAlD
Valproic Acid—SLC16A1—central nervous system—brain cancer	0.000363	0.00424	CbGeAlD
Valproic Acid—SLC16A1—cerebellum—brain cancer	0.000355	0.00415	CbGeAlD
Valproic Acid—CYP2A6—cerebellum—brain cancer	0.00035	0.00409	CbGeAlD
Valproic Acid—HDAC2—brain—brain cancer	0.000325	0.00379	CbGeAlD
Valproic Acid—SLC22A8—head—brain cancer	0.000301	0.00351	CbGeAlD
Valproic Acid—SLC22A5—pituitary gland—brain cancer	0.000297	0.00347	CbGeAlD
Valproic Acid—SLC16A1—brain—brain cancer	0.000289	0.00337	CbGeAlD
Valproic Acid—CYP2C8—pituitary gland—brain cancer	0.000288	0.00336	CbGeAlD
Valproic Acid—SLC22A5—medulla oblongata—brain cancer	0.000287	0.00335	CbGeAlD
Valproic Acid—PTGS1—telencephalon—brain cancer	0.000287	0.00335	CbGeAlD
Valproic Acid—CYP2A6—brain—brain cancer	0.000284	0.00332	CbGeAlD
Valproic Acid—SLC22A8—central nervous system—brain cancer	0.000275	0.00321	CbGeAlD
Valproic Acid—Stomatitis—Temozolomide—brain cancer	0.000266	0.00152	CcSEcCtD
Valproic Acid—Urinary tract infection—Temozolomide—brain cancer	0.000265	0.00152	CcSEcCtD
Valproic Acid—CYP2B6—gonad—brain cancer	0.000265	0.00309	CbGeAlD
Valproic Acid—SLC22A5—midbrain—brain cancer	0.000262	0.00306	CbGeAlD
Valproic Acid—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000262	0.0015	CcSEcCtD
Valproic Acid—Insomnia—Procarbazine—brain cancer	0.00026	0.00149	CcSEcCtD
Valproic Acid—Paraesthesia—Procarbazine—brain cancer	0.000258	0.00148	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Temozolomide—brain cancer	0.000258	0.00148	CcSEcCtD
Valproic Acid—SLC22A5—spinal cord—brain cancer	0.000256	0.00299	CbGeAlD
Valproic Acid—Sinusitis—Temozolomide—brain cancer	0.000256	0.00147	CcSEcCtD
Valproic Acid—Somnolence—Procarbazine—brain cancer	0.000256	0.00147	CcSEcCtD
Valproic Acid—CYP2C19—endocrine gland—brain cancer	0.000256	0.00298	CbGeAlD
Valproic Acid—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000255	0.00146	CcSEcCtD
Valproic Acid—Haemoglobin—Carmustine—brain cancer	0.000255	0.00146	CcSEcCtD
Valproic Acid—Haemorrhage—Carmustine—brain cancer	0.000253	0.00145	CcSEcCtD
Valproic Acid—Ill-defined disorder—Hydroxyurea—brain cancer	0.000253	0.00145	CcSEcCtD
Valproic Acid—Anaemia—Hydroxyurea—brain cancer	0.000252	0.00145	CcSEcCtD
Valproic Acid—Hallucination—Carmustine—brain cancer	0.000252	0.00145	CcSEcCtD
Valproic Acid—Hypoaesthesia—Carmustine—brain cancer	0.000252	0.00145	CcSEcCtD
Valproic Acid—Decreased appetite—Procarbazine—brain cancer	0.00025	0.00143	CcSEcCtD
Valproic Acid—Alanine aminotransferase increased—Etoposide—brain cancer	0.00025	0.00143	CcSEcCtD
Valproic Acid—Oedema peripheral—Carmustine—brain cancer	0.00025	0.00143	CcSEcCtD
Valproic Acid—Connective tissue disorder—Carmustine—brain cancer	0.000249	0.00143	CcSEcCtD
Valproic Acid—Fatigue—Procarbazine—brain cancer	0.000248	0.00142	CcSEcCtD
Valproic Acid—Haemoglobin—Temozolomide—brain cancer	0.000246	0.00141	CcSEcCtD
Valproic Acid—Malaise—Hydroxyurea—brain cancer	0.000246	0.00141	CcSEcCtD
Valproic Acid—Pain—Procarbazine—brain cancer	0.000246	0.00141	CcSEcCtD
Valproic Acid—Constipation—Procarbazine—brain cancer	0.000246	0.00141	CcSEcCtD
Valproic Acid—Haemorrhage—Temozolomide—brain cancer	0.000245	0.0014	CcSEcCtD
Valproic Acid—Dysphagia—Etoposide—brain cancer	0.000245	0.0014	CcSEcCtD
Valproic Acid—Leukopenia—Hydroxyurea—brain cancer	0.000244	0.0014	CcSEcCtD
Valproic Acid—Visual impairment—Carmustine—brain cancer	0.000244	0.0014	CcSEcCtD
Valproic Acid—Hallucination—Temozolomide—brain cancer	0.000244	0.0014	CcSEcCtD
Valproic Acid—Hypoaesthesia—Temozolomide—brain cancer	0.000244	0.0014	CcSEcCtD
Valproic Acid—Pharyngitis—Temozolomide—brain cancer	0.000243	0.00139	CcSEcCtD
Valproic Acid—Urinary tract disorder—Temozolomide—brain cancer	0.000242	0.00139	CcSEcCtD
Valproic Acid—Oedema peripheral—Temozolomide—brain cancer	0.000241	0.00138	CcSEcCtD
Valproic Acid—Connective tissue disorder—Temozolomide—brain cancer	0.000241	0.00138	CcSEcCtD
Valproic Acid—Urethral disorder—Temozolomide—brain cancer	0.00024	0.00138	CcSEcCtD
Valproic Acid—Sweating increased—Etoposide—brain cancer	0.000238	0.00137	CcSEcCtD
Valproic Acid—Feeling abnormal—Procarbazine—brain cancer	0.000237	0.00136	CcSEcCtD
Valproic Acid—Eye disorder—Carmustine—brain cancer	0.000237	0.00136	CcSEcCtD
Valproic Acid—Visual impairment—Temozolomide—brain cancer	0.000236	0.00135	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Procarbazine—brain cancer	0.000235	0.00135	CcSEcCtD
Valproic Acid—PTGS1—pituitary gland—brain cancer	0.000234	0.00273	CbGeAlD
Valproic Acid—Pancytopenia—Etoposide—brain cancer	0.000232	0.00133	CcSEcCtD
Valproic Acid—Erythema multiforme—Temozolomide—brain cancer	0.000231	0.00133	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000231	0.00132	CcSEcCtD
Valproic Acid—Discomfort—Hydroxyurea—brain cancer	0.000229	0.00132	CcSEcCtD
Valproic Acid—Neutropenia—Etoposide—brain cancer	0.000229	0.00131	CcSEcCtD
Valproic Acid—Eye disorder—Temozolomide—brain cancer	0.000229	0.00131	CcSEcCtD
Valproic Acid—Urticaria—Procarbazine—brain cancer	0.000228	0.00131	CcSEcCtD
Valproic Acid—Tinnitus—Temozolomide—brain cancer	0.000228	0.00131	CcSEcCtD
Valproic Acid—Abdominal pain—Procarbazine—brain cancer	0.000227	0.0013	CcSEcCtD
Valproic Acid—Body temperature increased—Procarbazine—brain cancer	0.000227	0.0013	CcSEcCtD
Valproic Acid—Arrhythmia—Carmustine—brain cancer	0.000226	0.0013	CcSEcCtD
Valproic Acid—Alopecia—Carmustine—brain cancer	0.000224	0.00128	CcSEcCtD
Valproic Acid—CYP2C8—endocrine gland—brain cancer	0.000223	0.0026	CbGeAlD
Valproic Acid—Oedema—Hydroxyurea—brain cancer	0.000223	0.00128	CcSEcCtD
Valproic Acid—Angiopathy—Temozolomide—brain cancer	0.000222	0.00127	CcSEcCtD
Valproic Acid—Mental disorder—Carmustine—brain cancer	0.000222	0.00127	CcSEcCtD
Valproic Acid—Infection—Hydroxyurea—brain cancer	0.000221	0.00127	CcSEcCtD
Valproic Acid—Immune system disorder—Temozolomide—brain cancer	0.000221	0.00127	CcSEcCtD
Valproic Acid—Mediastinal disorder—Temozolomide—brain cancer	0.000221	0.00127	CcSEcCtD
Valproic Acid—Malnutrition—Carmustine—brain cancer	0.00022	0.00127	CcSEcCtD
Valproic Acid—Chills—Temozolomide—brain cancer	0.00022	0.00126	CcSEcCtD
Valproic Acid—Pneumonia—Etoposide—brain cancer	0.000219	0.00126	CcSEcCtD
Valproic Acid—Nervous system disorder—Hydroxyurea—brain cancer	0.000218	0.00125	CcSEcCtD
Valproic Acid—SLC22A8—brain—brain cancer	0.000218	0.00255	CbGeAlD
Valproic Acid—Thrombocytopenia—Hydroxyurea—brain cancer	0.000218	0.00125	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000216	0.00124	CcSEcCtD
Valproic Acid—Alopecia—Temozolomide—brain cancer	0.000216	0.00124	CcSEcCtD
Valproic Acid—Skin disorder—Hydroxyurea—brain cancer	0.000216	0.00124	CcSEcCtD
Valproic Acid—Mental disorder—Temozolomide—brain cancer	0.000214	0.00123	CcSEcCtD
Valproic Acid—Back pain—Carmustine—brain cancer	0.000213	0.00122	CcSEcCtD
Valproic Acid—Malnutrition—Temozolomide—brain cancer	0.000213	0.00122	CcSEcCtD
Valproic Acid—Stomatitis—Etoposide—brain cancer	0.000213	0.00122	CcSEcCtD
Valproic Acid—Anorexia—Hydroxyurea—brain cancer	0.000212	0.00122	CcSEcCtD
Valproic Acid—Hypersensitivity—Procarbazine—brain cancer	0.000212	0.00122	CcSEcCtD
Valproic Acid—CYP1A2—endocrine gland—brain cancer	0.000209	0.00244	CbGeAlD
Valproic Acid—Dysgeusia—Temozolomide—brain cancer	0.000209	0.0012	CcSEcCtD
Valproic Acid—Vision blurred—Carmustine—brain cancer	0.000208	0.00119	CcSEcCtD
Valproic Acid—Tremor—Carmustine—brain cancer	0.000207	0.00119	CcSEcCtD
Valproic Acid—Asthenia—Procarbazine—brain cancer	0.000206	0.00118	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Etoposide—brain cancer	0.000206	0.00118	CcSEcCtD
Valproic Acid—Back pain—Temozolomide—brain cancer	0.000206	0.00118	CcSEcCtD
Valproic Acid—Anaemia—Carmustine—brain cancer	0.000204	0.00117	CcSEcCtD
Valproic Acid—Agranulocytosis—Etoposide—brain cancer	0.000204	0.00117	CcSEcCtD
Valproic Acid—Pruritus—Procarbazine—brain cancer	0.000203	0.00117	CcSEcCtD
Valproic Acid—SLC22A5—cerebellum—brain cancer	0.000203	0.00237	CbGeAlD
Valproic Acid—Agitation—Carmustine—brain cancer	0.000203	0.00116	CcSEcCtD
Valproic Acid—CYP3A5—endocrine gland—brain cancer	0.000201	0.00235	CbGeAlD
Valproic Acid—PTGS1—spinal cord—brain cancer	0.000201	0.00235	CbGeAlD
Valproic Acid—Vision blurred—Temozolomide—brain cancer	0.000201	0.00115	CcSEcCtD
Valproic Acid—CYP2B6—endocrine gland—brain cancer	0.0002	0.00234	CbGeAlD
Valproic Acid—Tremor—Temozolomide—brain cancer	0.0002	0.00115	CcSEcCtD
Valproic Acid—Dyspnoea—Hydroxyurea—brain cancer	0.000198	0.00114	CcSEcCtD
Valproic Acid—CYP2C9—endocrine gland—brain cancer	0.000198	0.00231	CbGeAlD
Valproic Acid—Somnolence—Hydroxyurea—brain cancer	0.000198	0.00114	CcSEcCtD
Valproic Acid—Ill-defined disorder—Temozolomide—brain cancer	0.000198	0.00113	CcSEcCtD
Valproic Acid—CYP2B6—head—brain cancer	0.000198	0.00231	CbGeAlD
Valproic Acid—Leukopenia—Carmustine—brain cancer	0.000197	0.00113	CcSEcCtD
Valproic Acid—Anaemia—Temozolomide—brain cancer	0.000197	0.00113	CcSEcCtD
Valproic Acid—Diarrhoea—Procarbazine—brain cancer	0.000197	0.00113	CcSEcCtD
Valproic Acid—Dyspepsia—Hydroxyurea—brain cancer	0.000196	0.00112	CcSEcCtD
Valproic Acid—Agitation—Temozolomide—brain cancer	0.000196	0.00112	CcSEcCtD
Valproic Acid—Hypoaesthesia—Etoposide—brain cancer	0.000195	0.00112	CcSEcCtD
Valproic Acid—Angioedema—Temozolomide—brain cancer	0.000195	0.00112	CcSEcCtD
Valproic Acid—Decreased appetite—Hydroxyurea—brain cancer	0.000193	0.00111	CcSEcCtD
Valproic Acid—Urinary tract disorder—Etoposide—brain cancer	0.000193	0.00111	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000192	0.0011	CcSEcCtD
Valproic Acid—Malaise—Temozolomide—brain cancer	0.000192	0.0011	CcSEcCtD
Valproic Acid—Urethral disorder—Etoposide—brain cancer	0.000192	0.0011	CcSEcCtD
Valproic Acid—Fatigue—Hydroxyurea—brain cancer	0.000192	0.0011	CcSEcCtD
Valproic Acid—Vertigo—Temozolomide—brain cancer	0.000191	0.0011	CcSEcCtD
Valproic Acid—Leukopenia—Temozolomide—brain cancer	0.000191	0.00109	CcSEcCtD
Valproic Acid—Hypertension—Carmustine—brain cancer	0.00019	0.00109	CcSEcCtD
Valproic Acid—Pain—Hydroxyurea—brain cancer	0.00019	0.00109	CcSEcCtD
Valproic Acid—Constipation—Hydroxyurea—brain cancer	0.00019	0.00109	CcSEcCtD
Valproic Acid—Dizziness—Procarbazine—brain cancer	0.00019	0.00109	CcSEcCtD
Valproic Acid—Palpitations—Temozolomide—brain cancer	0.000188	0.00108	CcSEcCtD
Valproic Acid—Myalgia—Carmustine—brain cancer	0.000188	0.00108	CcSEcCtD
Valproic Acid—Chest pain—Carmustine—brain cancer	0.000188	0.00108	CcSEcCtD
Valproic Acid—Anxiety—Carmustine—brain cancer	0.000187	0.00107	CcSEcCtD
Valproic Acid—Cough—Temozolomide—brain cancer	0.000186	0.00107	CcSEcCtD
Valproic Acid—Erythema multiforme—Etoposide—brain cancer	0.000185	0.00106	CcSEcCtD
Valproic Acid—Hypertension—Temozolomide—brain cancer	0.000184	0.00106	CcSEcCtD
Valproic Acid—Feeling abnormal—Hydroxyurea—brain cancer	0.000183	0.00105	CcSEcCtD
Valproic Acid—Eye disorder—Etoposide—brain cancer	0.000183	0.00105	CcSEcCtD
Valproic Acid—Vomiting—Procarbazine—brain cancer	0.000183	0.00105	CcSEcCtD
Valproic Acid—Confusional state—Carmustine—brain cancer	0.000181	0.00104	CcSEcCtD
Valproic Acid—Myalgia—Temozolomide—brain cancer	0.000181	0.00104	CcSEcCtD
Valproic Acid—Arthralgia—Temozolomide—brain cancer	0.000181	0.00104	CcSEcCtD
Valproic Acid—Rash—Procarbazine—brain cancer	0.000181	0.00104	CcSEcCtD
Valproic Acid—Dermatitis—Procarbazine—brain cancer	0.000181	0.00104	CcSEcCtD
Valproic Acid—PTGS1—endocrine gland—brain cancer	0.000181	0.00211	CbGeAlD
Valproic Acid—Anxiety—Temozolomide—brain cancer	0.000181	0.00104	CcSEcCtD
Valproic Acid—CYP2B6—central nervous system—brain cancer	0.00018	0.00211	CbGeAlD
Valproic Acid—Headache—Procarbazine—brain cancer	0.00018	0.00103	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00018	0.00103	CcSEcCtD
Valproic Acid—Oedema—Carmustine—brain cancer	0.00018	0.00103	CcSEcCtD
Valproic Acid—Discomfort—Temozolomide—brain cancer	0.000179	0.00103	CcSEcCtD
Valproic Acid—Infection—Carmustine—brain cancer	0.000179	0.00103	CcSEcCtD
Valproic Acid—PTGS1—head—brain cancer	0.000179	0.00209	CbGeAlD
Valproic Acid—Angiopathy—Etoposide—brain cancer	0.000178	0.00102	CcSEcCtD
Valproic Acid—Dry mouth—Temozolomide—brain cancer	0.000177	0.00102	CcSEcCtD
Valproic Acid—Immune system disorder—Etoposide—brain cancer	0.000177	0.00102	CcSEcCtD
Valproic Acid—Mediastinal disorder—Etoposide—brain cancer	0.000177	0.00101	CcSEcCtD
Valproic Acid—Thrombocytopenia—Carmustine—brain cancer	0.000176	0.00101	CcSEcCtD
Valproic Acid—Body temperature increased—Hydroxyurea—brain cancer	0.000176	0.00101	CcSEcCtD
Valproic Acid—Chills—Etoposide—brain cancer	0.000176	0.00101	CcSEcCtD
Valproic Acid—Tachycardia—Carmustine—brain cancer	0.000176	0.00101	CcSEcCtD
Valproic Acid—Confusional state—Temozolomide—brain cancer	0.000175	0.00101	CcSEcCtD
Valproic Acid—Oedema—Temozolomide—brain cancer	0.000174	0.000998	CcSEcCtD
Valproic Acid—Anaphylactic shock—Temozolomide—brain cancer	0.000174	0.000998	CcSEcCtD
Valproic Acid—Alopecia—Etoposide—brain cancer	0.000173	0.000993	CcSEcCtD
Valproic Acid—Infection—Temozolomide—brain cancer	0.000173	0.000991	CcSEcCtD
Valproic Acid—Anorexia—Carmustine—brain cancer	0.000172	0.000984	CcSEcCtD
Valproic Acid—Nausea—Procarbazine—brain cancer	0.000171	0.00098	CcSEcCtD
Valproic Acid—Nervous system disorder—Temozolomide—brain cancer	0.000171	0.000978	CcSEcCtD
Valproic Acid—Thrombocytopenia—Temozolomide—brain cancer	0.00017	0.000977	CcSEcCtD
Valproic Acid—Skin disorder—Temozolomide—brain cancer	0.000169	0.000969	CcSEcCtD
Valproic Acid—Hypotension—Carmustine—brain cancer	0.000168	0.000965	CcSEcCtD
Valproic Acid—Hyperhidrosis—Temozolomide—brain cancer	0.000168	0.000965	CcSEcCtD
Valproic Acid—Dysgeusia—Etoposide—brain cancer	0.000167	0.000958	CcSEcCtD
Valproic Acid—Anorexia—Temozolomide—brain cancer	0.000166	0.000951	CcSEcCtD
Valproic Acid—Back pain—Etoposide—brain cancer	0.000165	0.000946	CcSEcCtD
Valproic Acid—SLC22A5—brain—brain cancer	0.000165	0.00192	CbGeAlD
Valproic Acid—Hypersensitivity—Hydroxyurea—brain cancer	0.000164	0.000941	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Carmustine—brain cancer	0.000164	0.000941	CcSEcCtD
Valproic Acid—Muscle spasms—Etoposide—brain cancer	0.000164	0.000941	CcSEcCtD
Valproic Acid—PTGS1—central nervous system—brain cancer	0.000163	0.0019	CbGeAlD
Valproic Acid—Insomnia—Carmustine—brain cancer	0.000163	0.000934	CcSEcCtD
Valproic Acid—Paraesthesia—Carmustine—brain cancer	0.000162	0.000927	CcSEcCtD
Valproic Acid—Dyspnoea—Carmustine—brain cancer	0.00016	0.00092	CcSEcCtD
Valproic Acid—Somnolence—Carmustine—brain cancer	0.00016	0.000918	CcSEcCtD
Valproic Acid—Asthenia—Hydroxyurea—brain cancer	0.00016	0.000916	CcSEcCtD
Valproic Acid—CYP2C8—brain—brain cancer	0.00016	0.00186	CbGeAlD
Valproic Acid—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000158	0.000909	CcSEcCtD
Valproic Acid—Ill-defined disorder—Etoposide—brain cancer	0.000158	0.000908	CcSEcCtD
Valproic Acid—Anaemia—Etoposide—brain cancer	0.000158	0.000904	CcSEcCtD
Valproic Acid—Insomnia—Temozolomide—brain cancer	0.000157	0.000902	CcSEcCtD
Valproic Acid—Decreased appetite—Carmustine—brain cancer	0.000156	0.000898	CcSEcCtD
Valproic Acid—Paraesthesia—Temozolomide—brain cancer	0.000156	0.000896	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Carmustine—brain cancer	0.000155	0.000891	CcSEcCtD
Valproic Acid—Dyspnoea—Temozolomide—brain cancer	0.000155	0.00089	CcSEcCtD
Valproic Acid—Somnolence—Temozolomide—brain cancer	0.000155	0.000887	CcSEcCtD
Valproic Acid—Pain—Carmustine—brain cancer	0.000154	0.000883	CcSEcCtD
Valproic Acid—Constipation—Carmustine—brain cancer	0.000154	0.000883	CcSEcCtD
Valproic Acid—Malaise—Etoposide—brain cancer	0.000154	0.000882	CcSEcCtD
Valproic Acid—Vertigo—Etoposide—brain cancer	0.000153	0.000879	CcSEcCtD
Valproic Acid—Dyspepsia—Temozolomide—brain cancer	0.000153	0.000878	CcSEcCtD
Valproic Acid—Leukopenia—Etoposide—brain cancer	0.000153	0.000876	CcSEcCtD
Valproic Acid—Diarrhoea—Hydroxyurea—brain cancer	0.000152	0.000874	CcSEcCtD
Valproic Acid—Decreased appetite—Temozolomide—brain cancer	0.000151	0.000867	CcSEcCtD
Valproic Acid—CYP3A4—endocrine gland—brain cancer	0.000151	0.00176	CbGeAlD
Valproic Acid—Gastrointestinal disorder—Temozolomide—brain cancer	0.00015	0.000861	CcSEcCtD
Valproic Acid—Fatigue—Temozolomide—brain cancer	0.00015	0.00086	CcSEcCtD
Valproic Acid—Cough—Etoposide—brain cancer	0.000149	0.000854	CcSEcCtD
Valproic Acid—Pain—Temozolomide—brain cancer	0.000149	0.000853	CcSEcCtD
Valproic Acid—Constipation—Temozolomide—brain cancer	0.000149	0.000853	CcSEcCtD
Valproic Acid—Feeling abnormal—Carmustine—brain cancer	0.000148	0.000851	CcSEcCtD
Valproic Acid—Hypertension—Etoposide—brain cancer	0.000147	0.000845	CcSEcCtD
Valproic Acid—Dizziness—Hydroxyurea—brain cancer	0.000147	0.000845	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Carmustine—brain cancer	0.000147	0.000844	CcSEcCtD
Valproic Acid—Chest pain—Etoposide—brain cancer	0.000145	0.000833	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000144	0.000827	CcSEcCtD
Valproic Acid—Discomfort—Etoposide—brain cancer	0.000143	0.000823	CcSEcCtD
Valproic Acid—Feeling abnormal—Temozolomide—brain cancer	0.000143	0.000822	CcSEcCtD
Valproic Acid—CYP2B6—brain—brain cancer	0.000143	0.00167	CbGeAlD
Valproic Acid—Body temperature increased—Carmustine—brain cancer	0.000142	0.000816	CcSEcCtD
Valproic Acid—Abdominal pain—Carmustine—brain cancer	0.000142	0.000816	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Temozolomide—brain cancer	0.000142	0.000816	CcSEcCtD
Valproic Acid—Vomiting—Hydroxyurea—brain cancer	0.000142	0.000812	CcSEcCtD
Valproic Acid—Rash—Hydroxyurea—brain cancer	0.00014	0.000805	CcSEcCtD
Valproic Acid—Confusional state—Etoposide—brain cancer	0.00014	0.000805	CcSEcCtD
Valproic Acid—Dermatitis—Hydroxyurea—brain cancer	0.00014	0.000805	CcSEcCtD
Valproic Acid—Headache—Hydroxyurea—brain cancer	0.000139	0.0008	CcSEcCtD
Valproic Acid—Anaphylactic shock—Etoposide—brain cancer	0.000139	0.000798	CcSEcCtD
Valproic Acid—Infection—Etoposide—brain cancer	0.000138	0.000793	CcSEcCtD
Valproic Acid—Urticaria—Temozolomide—brain cancer	0.000138	0.000793	CcSEcCtD
Valproic Acid—Body temperature increased—Temozolomide—brain cancer	0.000137	0.000789	CcSEcCtD
Valproic Acid—Abdominal pain—Temozolomide—brain cancer	0.000137	0.000789	CcSEcCtD
Valproic Acid—Thrombocytopenia—Etoposide—brain cancer	0.000136	0.000782	CcSEcCtD
Valproic Acid—CYP3A4—central nervous system—brain cancer	0.000136	0.00159	CbGeAlD
Valproic Acid—Tachycardia—Etoposide—brain cancer	0.000136	0.000779	CcSEcCtD
Valproic Acid—Skin disorder—Etoposide—brain cancer	0.000135	0.000776	CcSEcCtD
Valproic Acid—Hyperhidrosis—Etoposide—brain cancer	0.000135	0.000772	CcSEcCtD
Valproic Acid—Anorexia—Etoposide—brain cancer	0.000133	0.000761	CcSEcCtD
Valproic Acid—Hypersensitivity—Carmustine—brain cancer	0.000133	0.000761	CcSEcCtD
Valproic Acid—Nausea—Hydroxyurea—brain cancer	0.000132	0.000759	CcSEcCtD
Valproic Acid—Hypotension—Etoposide—brain cancer	0.00013	0.000746	CcSEcCtD
Valproic Acid—PTGS1—brain—brain cancer	0.000129	0.00151	CbGeAlD
Valproic Acid—Asthenia—Carmustine—brain cancer	0.000129	0.000741	CcSEcCtD
Valproic Acid—Hypersensitivity—Temozolomide—brain cancer	0.000128	0.000735	CcSEcCtD
Valproic Acid—Paraesthesia—Etoposide—brain cancer	0.000125	0.000717	CcSEcCtD
Valproic Acid—Asthenia—Temozolomide—brain cancer	0.000125	0.000716	CcSEcCtD
Valproic Acid—Dyspnoea—Etoposide—brain cancer	0.000124	0.000712	CcSEcCtD
Valproic Acid—Somnolence—Etoposide—brain cancer	0.000124	0.00071	CcSEcCtD
Valproic Acid—Diarrhoea—Carmustine—brain cancer	0.000123	0.000706	CcSEcCtD
Valproic Acid—Pruritus—Temozolomide—brain cancer	0.000123	0.000706	CcSEcCtD
Valproic Acid—Decreased appetite—Etoposide—brain cancer	0.000121	0.000694	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Etoposide—brain cancer	0.00012	0.000689	CcSEcCtD
Valproic Acid—Fatigue—Etoposide—brain cancer	0.00012	0.000688	CcSEcCtD
Valproic Acid—Dizziness—Carmustine—brain cancer	0.000119	0.000683	CcSEcCtD
Valproic Acid—Pain—Etoposide—brain cancer	0.000119	0.000683	CcSEcCtD
Valproic Acid—Constipation—Etoposide—brain cancer	0.000119	0.000683	CcSEcCtD
Valproic Acid—Diarrhoea—Temozolomide—brain cancer	0.000119	0.000683	CcSEcCtD
Valproic Acid—Dizziness—Temozolomide—brain cancer	0.000115	0.00066	CcSEcCtD
Valproic Acid—Feeling abnormal—Etoposide—brain cancer	0.000115	0.000658	CcSEcCtD
Valproic Acid—Vomiting—Carmustine—brain cancer	0.000114	0.000656	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Etoposide—brain cancer	0.000114	0.000653	CcSEcCtD
Valproic Acid—Rash—Carmustine—brain cancer	0.000113	0.000651	CcSEcCtD
Valproic Acid—Dermatitis—Carmustine—brain cancer	0.000113	0.00065	CcSEcCtD
Valproic Acid—Headache—Carmustine—brain cancer	0.000113	0.000647	CcSEcCtD
Valproic Acid—Vomiting—Temozolomide—brain cancer	0.000111	0.000634	CcSEcCtD
Valproic Acid—Urticaria—Etoposide—brain cancer	0.000111	0.000634	CcSEcCtD
Valproic Acid—Body temperature increased—Etoposide—brain cancer	0.00011	0.000631	CcSEcCtD
Valproic Acid—Abdominal pain—Etoposide—brain cancer	0.00011	0.000631	CcSEcCtD
Valproic Acid—Rash—Temozolomide—brain cancer	0.00011	0.000629	CcSEcCtD
Valproic Acid—Dermatitis—Temozolomide—brain cancer	0.00011	0.000629	CcSEcCtD
Valproic Acid—Headache—Temozolomide—brain cancer	0.000109	0.000625	CcSEcCtD
Valproic Acid—Nausea—Carmustine—brain cancer	0.000107	0.000613	CcSEcCtD
Valproic Acid—Nausea—Temozolomide—brain cancer	0.000103	0.000593	CcSEcCtD
Valproic Acid—Hypersensitivity—Etoposide—brain cancer	0.000103	0.000588	CcSEcCtD
Valproic Acid—Asthenia—Etoposide—brain cancer	9.98e-05	0.000573	CcSEcCtD
Valproic Acid—Pruritus—Etoposide—brain cancer	9.84e-05	0.000565	CcSEcCtD
Valproic Acid—Diarrhoea—Etoposide—brain cancer	9.52e-05	0.000546	CcSEcCtD
Valproic Acid—Dizziness—Etoposide—brain cancer	9.2e-05	0.000528	CcSEcCtD
Valproic Acid—Vomiting—Etoposide—brain cancer	8.85e-05	0.000508	CcSEcCtD
Valproic Acid—Rash—Etoposide—brain cancer	8.77e-05	0.000503	CcSEcCtD
Valproic Acid—Dermatitis—Etoposide—brain cancer	8.77e-05	0.000503	CcSEcCtD
Valproic Acid—Headache—Etoposide—brain cancer	8.72e-05	0.0005	CcSEcCtD
Valproic Acid—Nausea—Etoposide—brain cancer	8.27e-05	0.000474	CcSEcCtD
Valproic Acid—UGT1A8—Metabolism—IDH1—brain cancer	7.16e-05	0.000526	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—SHH—brain cancer	7.16e-05	0.000525	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—ENO2—brain cancer	7.16e-05	0.000525	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—CYP2C9—brain cancer	7.15e-05	0.000525	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.12e-05	0.000522	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	7.08e-05	0.00052	CbGpPWpGaD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	7.01e-05	0.000514	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	7e-05	0.000514	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—GLI1—brain cancer	6.93e-05	0.000509	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—CCND1—brain cancer	6.89e-05	0.000506	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—CYP2C9—brain cancer	6.79e-05	0.000498	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TRPC6—brain cancer	6.76e-05	0.000496	CbGpPWpGaD
Valproic Acid—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	6.69e-05	0.000491	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SUFU—brain cancer	6.57e-05	0.000483	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—OR4C12—brain cancer	6.55e-05	0.000481	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—OR14C36—brain cancer	6.55e-05	0.000481	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—CDK4—brain cancer	6.54e-05	0.00048	CbGpPWpGaD
Valproic Acid—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	6.41e-05	0.000471	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—GFAP—brain cancer	6.34e-05	0.000466	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—IDH1—brain cancer	6.26e-05	0.00046	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TRPC6—brain cancer	6.18e-05	0.000454	CbGpPWpGaD
Valproic Acid—HDAC2—Chromatin modifying enzymes—CDK4—brain cancer	6.15e-05	0.000452	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—BSG—brain cancer	6.08e-05	0.000446	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HEY1—brain cancer	6.01e-05	0.000441	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—PDGFRA—brain cancer	5.99e-05	0.00044	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—DLL1—brain cancer	5.9e-05	0.000433	CbGpPWpGaD
Valproic Acid—HDAC2—Neural Crest Differentiation—MYC—brain cancer	5.88e-05	0.000431	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.85e-05	0.00043	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HES5—brain cancer	5.84e-05	0.000428	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.8e-05	0.000426	CbGpPWpGaD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—TP53—brain cancer	5.7e-05	0.000418	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—ENO2—brain cancer	5.66e-05	0.000416	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—DTX2—brain cancer	5.57e-05	0.000409	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—MYC—brain cancer	5.53e-05	0.000406	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CYP2C9—brain cancer	5.52e-05	0.000405	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—TRPC6—brain cancer	5.42e-05	0.000397	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	5.35e-05	0.000393	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—IRS2—brain cancer	5.26e-05	0.000386	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.24e-05	0.000384	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—IDH1—brain cancer	5.23e-05	0.000384	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.2e-05	0.000382	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—VAV1—brain cancer	5.17e-05	0.00038	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.17e-05	0.000379	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—VAV1—brain cancer	5.07e-05	0.000372	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—TRPC6—brain cancer	5.03e-05	0.000369	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SHH—brain cancer	5.01e-05	0.000368	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—ENO2—brain cancer	4.95e-05	0.000363	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—PIK3CG—brain cancer	4.94e-05	0.000363	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CYP2C9—brain cancer	4.92e-05	0.000361	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TRPC6—brain cancer	4.83e-05	0.000355	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—TP53—brain cancer	4.79e-05	0.000351	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PTCH1—brain cancer	4.75e-05	0.000349	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SMO—brain cancer	4.75e-05	0.000349	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—BSG—brain cancer	4.69e-05	0.000344	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—VAV1—brain cancer	4.63e-05	0.00034	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CYP2C9—brain cancer	4.59e-05	0.000337	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—TRPC6—brain cancer	4.55e-05	0.000334	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—TP53—brain cancer	4.54e-05	0.000333	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—HES1—brain cancer	4.45e-05	0.000327	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—EGFR—brain cancer	4.43e-05	0.000325	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.24e-05	0.000311	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PDGFRA—brain cancer	4.24e-05	0.000311	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTCH2—brain cancer	4.22e-05	0.00031	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—PIK3CG—brain cancer	4.2e-05	0.000309	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—BSG—brain cancer	4.18e-05	0.000307	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—ENO2—brain cancer	4.13e-05	0.000303	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HES5—brain cancer	4.09e-05	0.0003	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.04e-05	0.000296	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—IDH1—brain cancer	4.03e-05	0.000296	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CYP2C9—brain cancer	4.01e-05	0.000294	CbGpPWpGaD
Valproic Acid—HDAC2—Chromatin modifying enzymes—CCND1—brain cancer	3.97e-05	0.000292	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STRADA—brain cancer	3.97e-05	0.000291	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IDH1—brain cancer	3.93e-05	0.000288	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CYP2C9—brain cancer	3.9e-05	0.000286	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—BSG—brain cancer	3.9e-05	0.000286	CbGpPWpGaD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—brain cancer	3.8e-05	0.000279	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NOTCH2—brain cancer	3.8e-05	0.000279	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	3.8e-05	0.000279	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.75e-05	0.000275	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HEY1—brain cancer	3.72e-05	0.000273	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—IRS2—brain cancer	3.72e-05	0.000273	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—TP53—brain cancer	3.72e-05	0.000273	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—DLL1—brain cancer	3.65e-05	0.000268	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	3.64e-05	0.000267	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—RELA—brain cancer	3.63e-05	0.000266	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—VAV1—brain cancer	3.62e-05	0.000266	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—ERBB2—brain cancer	3.61e-05	0.000265	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—IDH1—brain cancer	3.6e-05	0.000264	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—BSG—brain cancer	3.41e-05	0.00025	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—IDH1—brain cancer	3.35e-05	0.000246	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.34e-05	0.000245	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—BSG—brain cancer	3.32e-05	0.000243	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ABR—brain cancer	3.31e-05	0.000243	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—APC—brain cancer	3.28e-05	0.000241	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—PIK3CG—brain cancer	3.22e-05	0.000236	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GLI2—brain cancer	3.2e-05	0.000235	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ENO2—brain cancer	3.19e-05	0.000234	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CYP2C9—brain cancer	3.17e-05	0.000233	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HES1—brain cancer	3.12e-05	0.000229	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ENO2—brain cancer	3.1e-05	0.000228	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SHH—brain cancer	3.1e-05	0.000228	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.09e-05	0.000227	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GLI1—brain cancer	3.01e-05	0.000221	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—DNMT1—brain cancer	2.98e-05	0.000219	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PDGFRA—brain cancer	2.97e-05	0.000218	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—PIK3CG—brain cancer	2.94e-05	0.000216	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—IDH1—brain cancer	2.93e-05	0.000215	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SPP1—brain cancer	2.88e-05	0.000211	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—IDH1—brain cancer	2.85e-05	0.000209	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SUFU—brain cancer	2.85e-05	0.000209	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.84e-05	0.000209	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ENO2—brain cancer	2.84e-05	0.000209	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—TP53—brain cancer	2.78e-05	0.000204	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.78e-05	0.000204	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.78e-05	0.000204	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GFAP—brain cancer	2.75e-05	0.000202	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—STAT3—brain cancer	2.75e-05	0.000202	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.74e-05	0.000201	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—BSG—brain cancer	2.69e-05	0.000198	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—ESR2—brain cancer	2.68e-05	0.000196	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ENO2—brain cancer	2.65e-05	0.000195	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HEY1—brain cancer	2.61e-05	0.000191	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.61e-05	0.000191	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IRS2—brain cancer	2.6e-05	0.000191	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PIK3CG—brain cancer	2.6e-05	0.000191	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP2C9—brain cancer	2.58e-05	0.00019	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—DLL1—brain cancer	2.56e-05	0.000188	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—ERBB2—brain cancer	2.55e-05	0.000187	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—NOTCH2—brain cancer	2.53e-05	0.000186	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—EGFR—brain cancer	2.5e-05	0.000183	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.45e-05	0.000179	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP2C9—brain cancer	2.44e-05	0.000179	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—IDH1—brain cancer	2.32e-05	0.00017	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ENO2—brain cancer	2.32e-05	0.00017	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—APC—brain cancer	2.3e-05	0.000169	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PIK3CG—brain cancer	2.3e-05	0.000169	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PIK3CG—brain cancer	2.27e-05	0.000167	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—IL2—brain cancer	2.26e-05	0.000166	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ENO2—brain cancer	2.25e-05	0.000165	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—VAV1—brain cancer	2.24e-05	0.000165	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CTNNB1—brain cancer	2.23e-05	0.000164	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.23e-05	0.000164	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—BSG—brain cancer	2.2e-05	0.000161	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SHH—brain cancer	2.17e-05	0.00016	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—SIRT1—brain cancer	2.15e-05	0.000158	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TRPC6—brain cancer	2.1e-05	0.000154	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—BSG—brain cancer	2.08e-05	0.000152	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—IL2—brain cancer	2.07e-05	0.000152	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTCH1—brain cancer	2.06e-05	0.000151	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SMO—brain cancer	2.06e-05	0.000151	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP2C9—brain cancer	1.97e-05	0.000145	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—STAT3—brain cancer	1.94e-05	0.000143	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HES1—brain cancer	1.93e-05	0.000142	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP2C9—brain cancer	1.93e-05	0.000141	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—VEGFA—brain cancer	1.92e-05	0.000141	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.91e-05	0.00014	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PIK3CG—brain cancer	1.89e-05	0.000139	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—IDH1—brain cancer	1.89e-05	0.000139	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.89e-05	0.000138	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PDGFRA—brain cancer	1.84e-05	0.000135	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ENO2—brain cancer	1.83e-05	0.000134	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MYC—brain cancer	1.81e-05	0.000133	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RELA—brain cancer	1.8e-05	0.000132	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—IDH1—brain cancer	1.79e-05	0.000131	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—ERBB2—brain cancer	1.79e-05	0.000131	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—EGFR—brain cancer	1.77e-05	0.00013	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—VEGFA—brain cancer	1.76e-05	0.000129	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—BSG—brain cancer	1.68e-05	0.000123	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP2C9—brain cancer	1.67e-05	0.000122	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NOTCH2—brain cancer	1.65e-05	0.000121	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—BSG—brain cancer	1.64e-05	0.00012	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL2—brain cancer	1.62e-05	0.000119	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IRS2—brain cancer	1.61e-05	0.000118	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCND1—brain cancer	1.58e-05	0.000116	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VAV1—brain cancer	1.57e-05	0.000115	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CTNNB1—brain cancer	1.56e-05	0.000115	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.54e-05	0.000113	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ENO2—brain cancer	1.49e-05	0.00011	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP2C9—brain cancer	1.49e-05	0.000109	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PIK3CG—brain cancer	1.46e-05	0.000107	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—brain cancer	1.45e-05	0.000107	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—IDH1—brain cancer	1.44e-05	0.000106	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—APC—brain cancer	1.42e-05	0.000105	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—BSG—brain cancer	1.42e-05	0.000104	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ENO2—brain cancer	1.41e-05	0.000104	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—IDH1—brain cancer	1.41e-05	0.000103	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—VEGFA—brain cancer	1.38e-05	0.000101	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—STAT3—brain cancer	1.36e-05	0.0001	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HES1—brain cancer	1.35e-05	9.91e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—brain cancer	1.33e-05	9.76e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CG—brain cancer	1.3e-05	9.57e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PDGFRA—brain cancer	1.29e-05	9.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—BSG—brain cancer	1.27e-05	9.3e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MYC—brain cancer	1.27e-05	9.29e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SPP1—brain cancer	1.25e-05	9.16e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EGFR—brain cancer	1.24e-05	9.09e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—IDH1—brain cancer	1.22e-05	8.96e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CG—brain cancer	1.22e-05	8.93e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP2C9—brain cancer	1.16e-05	8.52e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—BSG—brain cancer	1.15e-05	8.48e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ENO2—brain cancer	1.14e-05	8.36e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IRS2—brain cancer	1.13e-05	8.29e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ENO2—brain cancer	1.11e-05	8.17e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ERBB2—brain cancer	1.11e-05	8.12e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—IDH1—brain cancer	1.09e-05	7.99e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CG—brain cancer	1.06e-05	7.8e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—brain cancer	1.04e-05	7.63e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CG—brain cancer	1.03e-05	7.59e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—APC—brain cancer	9.97e-06	7.32e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CG—brain cancer	9.97e-06	7.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.94e-06	7.29e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—IDH1—brain cancer	9.93e-06	7.29e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—BSG—brain cancer	9.87e-06	7.24e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CTNNB1—brain cancer	9.67e-06	7.1e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ENO2—brain cancer	9.65e-06	7.08e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP2C9—brain cancer	8.96e-06	6.57e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.87e-06	6.51e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ENO2—brain cancer	8.61e-06	6.32e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—IDH1—brain cancer	8.49e-06	6.23e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MYC—brain cancer	8.44e-06	6.19e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—STAT3—brain cancer	8.43e-06	6.19e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CG—brain cancer	8.4e-06	6.17e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.09e-06	5.93e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ENO2—brain cancer	7.85e-06	5.76e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MYC—brain cancer	7.84e-06	5.75e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RELA—brain cancer	7.79e-06	5.72e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ERBB2—brain cancer	7.74e-06	5.68e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—brain cancer	7.66e-06	5.63e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—BSG—brain cancer	7.62e-06	5.59e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL2—brain cancer	7.02e-06	5.15e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.91e-06	5.07e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CG—brain cancer	6.85e-06	5.03e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—brain cancer	6.84e-06	5.02e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CTNNB1—brain cancer	6.78e-06	4.97e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ENO2—brain cancer	6.71e-06	4.92e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—IDH1—brain cancer	6.55e-06	4.81e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CG—brain cancer	6.48e-06	4.75e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—brain cancer	5.96e-06	4.38e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STAT3—brain cancer	5.91e-06	4.33e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MYC—brain cancer	5.49e-06	4.03e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—brain cancer	5.37e-06	3.94e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CG—brain cancer	5.23e-06	3.84e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ENO2—brain cancer	5.18e-06	3.8e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CG—brain cancer	5.11e-06	3.75e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—brain cancer	4.51e-06	3.31e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CG—brain cancer	4.42e-06	3.25e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CG—brain cancer	3.95e-06	2.9e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CG—brain cancer	3.6e-06	2.64e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CG—brain cancer	3.08e-06	2.26e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CG—brain cancer	2.38e-06	1.74e-05	CbGpPWpGaD
